Patent details

EP2914590 Title: NOVEL ROCK INHIBITORS

Basic Information

Publication number:
EP2914590
PCT Application Number:
PCT/EP/2013/072774
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137864559
PCT Publication Number:
WO/2014/068035
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL ROCK INHIBITORS
French Title of Invention:
NOUVEAUX INHIBITEURS DE ROCK
German Title of Invention:
NEUARTIGE ROCK-INHIBITOREN
SPC Number:

Dates

Filing date:
31/10/2013
Grant date:
30/11/2016
EP Publication Date:
30/11/2016
PCT Publication Date:
08/05/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/09/2015
EP B1 Publication Date:
30/11/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
31/10/2023
Expiration date:
31/10/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/10/2013
 
 

Name:
pH Pharma Co. Ltd.
Address:
2F., Artside Gallery 15 Jahamun-Ro 6-Gil, Jongno-Gu Seoul 03044, Korea (Republic) (KR)

Inventor

1

Name:
LEYSEN Dirk
Address:
Belgium (BE)

2

Name:
BOURIN Arnaud, Pierre, Jean
Address:
Belgium (BE)

3

Name:
DEFERT Olivier
Address:
Belgium (BE)

4

Name:
BOLAND Sandro
Address:
Belgium (BE)

Priority

Priority Number:
12190859
Priority Date:
31/10/2012
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07D 405/14;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
20/10/2022
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages